Pharmafile Logo
Pharmafocus logo
Advanced Search

Another Day Pharma

Showing 1 posts of 1 posts found.

Another Day Pharma announces successful Phase II trial results for BZ371A in post-prostatectomy erectile dysfunction 

May 22, 2025
Research and Development Another Day Pharma, Genito-Urinary system, clinical trial, erectile dysfunction, prostate cancer, prostatectomy

First-in-class therapeutic peptide BZ371A confirmed as effective and well-tolerated  20 May 2025. Another Day Pharma Ltd, a company developing innovative …

News
Press release
The Gateway to Local Adoption Series

Latest content

NanoSomiX and Beckman Coulter Diagnostics collaborate on blood tests for neurodegenerative diseases

July 30, 2026

EMA selects TrialAssure anonymisation platform for clinical trial documents

July 30, 2026

Researchers develop new antifungal compounds with improved safety profile

July 29, 2026

Lonza and Engitix partner to develop next-generation antibody-drug conjugates

July 28, 2026

Simris Group appoints Tiffany J Vora as Strategic Advisor

July 28, 2026